Video

When to Discuss Clinical Trials with Patients

Patricia Spears discusses what clinical trials can offer and when to start discussing them with patients. This video was filmed December 11 at the 2019 San Antonio Breast Cancer Symposium.

Patricia Spears: I think clinical trials are really important for every patient that’s been diagnosed with cancer, and I think it’s never too early to talk to patients about clinical trials—that they are an option and they are out there. People do clinical trials for all different reasons. A lot of them are for altruism, you know, to move the field forward, and then others actually go to clinical trials as their next treatment choice, possibly to get a new medication. So, I think that in all spectrums of breast cancer, you should start talking about clinical trials at the beginning so that they’re always on the table as an option for patients.

Related Videos
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.